ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,857Medicare Part D Prescriptions Filled, Including Refills

Rank: 57 out of 229

$619K Total Retail Price of All Prescriptions

Rank: 30 out of 229

483 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 483 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

18% of this provider’s 483 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 7,097 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 421 406 1 1
SIMVASTATIN 341 308 2 3
LISINOPRIL 286 270 3 2
HYDROCODONE-ACETAMINOPHEN 281 245 S3 4 7
METOPROLOL TARTRATE 164 151 5 13
GABAPENTIN 156 110 6 10
AMLODIPINE BESYLATE 145 144 7 5
ALENDRONATE SODIUM 135 131 8 14
OMEPRAZOLE 131 122 9 4
HYDROCHLOROTHIAZIDE 126 123 10 9
FUROSEMIDE 122 113 11 8
WARFARIN SODIUM 121 110 12 17
ZOLPIDEM TARTRATE 117 110 13 20
OXYCONTIN 113 80 S2 14 88
NAMENDA 112 112 15 39
LOVASTATIN 104 97 16 11
LOSARTAN POTASSIUM 102 102 17 12
CITALOPRAM HBR 101 98 18 21
TAMSULOSIN HCL 100 100 19 24
FLUTICASONE PROPIONATE 98 74 20 23
SPIRONOLACTONE 94 89 21 56
PREDNISONE 92 88 22 35
METOPROLOL SUCCINATE 92 87 22 16
ATORVASTATIN CALCIUM 87 84 24 15
CRESTOR 83 82 25 30
METFORMIN HCL 82 77 26 6
CELEBREX 74 74 27 71
ALLOPURINOL 73 69 28 27
OXYCODONE-ACETAMINOPHEN 71 66 S2 29 43
SERTRALINE HCL 70 70 30 22
NIASPAN 65 65 31 166
ATENOLOL 65 53 31 19
POTASSIUM CHLORIDE 63 62 33 18
MIRTAZAPINE 63 63 33 52
DONEPEZIL HCL 59 59 35 29
SYNTHROID 59 59 35 46
OXYCODONE HCL-ACETAMINOPHEN 59 35 S2 35 73
SPIRIVA 56 55 38 76
FLUOXETINE HCL 53 45 39 41
ADVAIR DISKUS 52 49 40 47
FINASTERIDE 51 51 41 55
VENLAFAXINE HCL 51 47 41 145
CIPROFLOXACIN HCL 51 48 41 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.